Search

Search Results
Results 28681 - 28690 of 31566 for Acute
  • Stilnox CR
    Drug - 25 May 2026
    Consumer Medicine Information (CMI) about Stilnox CR intended for persons living in Australia.
  • Health experts outline symptoms and risks of shipboard hantavirus
    News - 18 May 2026
    It's one of the cruisegoer's biggest fears: a contagious disease outbreak at sea.
  • Silent heart attacks may speed cognitive decline
    News - 18 May 2026
    Research shows hidden heart attacks accelerate cognitive decline, highlighting the need for better identification of cardiovascular risks to brain health.
  • How Andes virus super-spreaders reveal the risk behind the MV Hondius hantavirus cluster
    News - 14 May 2026
    A 2020 NEJM study of the 2018 to 2019 Epuyén outbreak showed that Andes virus spread from one zoonotic introduction into four generations of human infection, causing 34 cases and 11 deaths. The...
  • Targocid
    Drug - 12 May 2026
    Consumer Medicine Information (CMI) about Targocid intended for persons living in Australia.
  • Aldurazyme
    Drug - 11 May 2026
    Consumer Medicine Information (CMI) about Aldurazyme intended for persons living in Australia.
  • Tripacel
    Drug - 8 May 2026
    Consumer Medicine Information (CMI) about Tripacel intended for persons living in Australia.
  • Jorveza
    Drug - 8 May 2026
    Consumer Medicine Information (CMI) about Jorveza intended for persons living in Australia.
  • Evoltra
    Drug - 5 May 2026
    Consumer Medicine Information (CMI) about Evoltra intended for persons living in Australia.
  • Iscover
    Drug - 1 May 2026
    Consumer Medicine Information (CMI) about Iscover intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback